Company Profile
Zeria Pharmaceutical manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and globally.
Its operations are structured into Ethical Pharmaceuticals Business and Consumer Healthcare Business segments cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment.
It also offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn's disease, and gastritis and ulcers. Its portfolio also includes zinc containing anti-ulcerants, oral bowel cleansing agents, laxatives, therapeutic agents for hypophosphatemia, and iron deficiency anemia, long-acting calcium channel blockers, oral NSAID, anti-leukopenia after radiotherapy products, and non-steroidal anti-inflammatory ophthalmic solutions
Consumer healthcare products, such as nutritional health drugs, remedies for gastrointestinal diseases, western herbal medicines, cold remedies, ophthalmic solutions, anti-inflammatory/analgesics, hemorroidal remedies, dermal remedies, quasi-drugs/cosmetics, nutrient tonics, soft drinks/health foods, and food for specified health uses.
It also engages in insurance agency and real estate business. Incorporated in 1955 and headquartered in Tokyo, Japan, Zeria Pharmaceutical was formerly known as Zeria Yakusho Kenkyusho Co., Ltd. before rebranding in May 1970.